Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
06/08/2026 21:02
BRIEF-Voyager Therapeutics Q2 Net Income USD -24.473 Million Aug 06 (Reuters) - Voyager Therapeutics Q2 basic EPS USD -0.4.
- Q2 collaboration revenue USD 3.165 million
- Q2 operating income USD -26.392 million
- Q2 pretax profit USD -24.453 million
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview